These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35326838)

  • 1. Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible
    Alsowaida YS; Benitez G; Bin Saleh K; Almangour TA; Shehadeh F; Mylonakis E
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Outpatient Parenteral Antimicrobial Therapy With Ceftriaxone for Methicillin-Susceptible
    Hamad Y; Connor L; Bailey TC; George IA
    Open Forum Infect Dis; 2020 Sep; 7(9):ofaa341. PubMed ID: 32908944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive
    Hamad Y; Nickel KB; Olsen MA; George IA
    Open Forum Infect Dis; 2024 Feb; 11(2):ofad662. PubMed ID: 38352150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible
    Ganguly A; de la Flor C; Alvarez K; Brown LS; Mang NS; Smartt J; King H; Perl TM; Filizola H; Bhavan KP
    Ann Pharmacother; 2023 Apr; 57(4):425-431. PubMed ID: 35942602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible staphylococcal aureus (MSSA) bloodstream infections.
    Patel UC; McKissic EL; Kasper D; Lentino JR; Pachucki CT; Lee T; Lopansri BK
    Int J Clin Pharm; 2014 Dec; 36(6):1282-9. PubMed ID: 25186790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis.
    Yetmar ZA; Razi S; Nayfeh T; Gerberi DJ; Mahmood M; Abu Saleh OM
    Int J Antimicrob Agents; 2022 Jan; 59(1):106486. PubMed ID: 34839007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible
    Barber KE; Cramer RA; Bell AM; Wagner JL; Stover KR
    Case Rep Infect Dis; 2021; 2021():8884685. PubMed ID: 33986964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone for the Treatment of Methicillin-susceptible
    Lowe RA; Barber KE; Wagner JL; Bell-Harlan AM; Stover KR
    J Pharmacol Pharmacother; 2017; 8(3):140-144. PubMed ID: 29081626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
    Yetmar ZA; Khodadadi RB; Go JR; Chesdachai S; Abu Saleh OM
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):423-430. PubMed ID: 36800065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible
    Carr DR; Stiefel U; Bonomo RA; Burant CJ; Sims SV
    Open Forum Infect Dis; 2018 May; 5(5):ofy089. PubMed ID: 30568987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis.
    Eljaaly K; Wali H; Basilim A; Alharbi A; Asfour HZ
    Int J Antimicrob Agents; 2019 Aug; 54(2):149-153. PubMed ID: 31173864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
    Chan M; Ooi CK; Wong J; Zhong L; Lye D
    BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone.
    Winans SA; Luce AM; Hasbun R
    Infection; 2013 Aug; 41(4):769-74. PubMed ID: 23686435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible
    Kufel WD; Zagoria Z; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Ann Pharmacother; 2024 Apr; 58(4):360-365. PubMed ID: 37542415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible
    Kamfose MM; Muriithi FG; Knight T; Lasserson D; Hayward G
    Antibiotics (Basel); 2020 Jan; 9(2):. PubMed ID: 31972972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia.
    Mohamed A; Bennett N; Ploetz J; Aragon L; Kennedy K; Boyd S
    Int J Antimicrob Agents; 2022 Sep; 60(3):106632. PubMed ID: 35787919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with β-lactam antibiotics in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections.
    Ye C; Wang Z; Hu Y; Deng C; Liao L; Sun L; Wang C
    J Glob Antimicrob Resist; 2020 Dec; 23():303-310. PubMed ID: 33045437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis.
    Shi C; Xiao Y; Zhang Q; Li Q; Wang F; Wu J; Lin N
    BMC Infect Dis; 2018 Oct; 18(1):508. PubMed ID: 30305037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twice daily cefazolin is effective for treatment of serious methicillin-sensitive
    Birrell MT; Fuller A
    Ther Adv Infect Dis; 2019; 6():2049936119882847. PubMed ID: 31839941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.